Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joud Hirbawi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancers|January 8, 2023
Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer TreatmentNoa Hauser, Joud Hirbawi, Meshi Saban Golub, et al.
Life (Basel, Switzerland)|September 28, 2021
TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human DiseasesMichal Lichtenstein, Samar Zabit, Noa Hauser, et al.
Nature Communications|October 3, 2024
Cathepsin B promotes Aβ proteotoxicity by modulating aging regulating mechanismsAtif Ahmed Siddiqui, Emmanuelle Merquiol, Reut Bruck-Haimson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancers|January 8, 2023
Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer TreatmentNoa Hauser, Joud Hirbawi, Meshi Saban Golub, et al.
Life (Basel, Switzerland)|September 28, 2021
TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human DiseasesMichal Lichtenstein, Samar Zabit, Noa Hauser, et al.
Nature Communications|October 3, 2024
Cathepsin B promotes Aβ proteotoxicity by modulating aging regulating mechanismsAtif Ahmed Siddiqui, Emmanuelle Merquiol, Reut Bruck-Haimson, et al.
Pageof 1